LLY: Bearish Trend and Short-term Risk
🔥 LucanInvstor's Strategy:
🩸 Short: Below $738.05, targeting $720 and $700. The MACD remains negative, and the price is below both the 9-day and 200-day EMAs, signaling a continued downtrend in the short term.
🩸 Long: Above $824.17, targeting $830 and $850. A break above resistance could resume the bullish trend, but caution is needed due to current bearish pressures.
🔥 LucanInvstor's Commands:
🩸 Resistance: $824.17 — A key resistance level; breaking above this could trigger further upside.
🩸 Support: $738.05 — A critical support level; a breakdown below this could lead to further declines.
Eli Lilly is under bearish pressure in the short term, with increasing selling volume and negative MACD momentum. A breakdown below support could lead to a further pullback, while a breakout above resistance could signal a reversal of the current trend.
👑 "In the face of adversity, clarity in action drives success."
🩸 Short: Below $738.05, targeting $720 and $700. The MACD remains negative, and the price is below both the 9-day and 200-day EMAs, signaling a continued downtrend in the short term.
🩸 Long: Above $824.17, targeting $830 and $850. A break above resistance could resume the bullish trend, but caution is needed due to current bearish pressures.
🔥 LucanInvstor's Commands:
🩸 Resistance: $824.17 — A key resistance level; breaking above this could trigger further upside.
🩸 Support: $738.05 — A critical support level; a breakdown below this could lead to further declines.
Eli Lilly is under bearish pressure in the short term, with increasing selling volume and negative MACD momentum. A breakdown below support could lead to a further pullback, while a breakout above resistance could signal a reversal of the current trend.
👑 "In the face of adversity, clarity in action drives success."
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.